Literature DB >> 24427763

Vaccine allergies.

Eun Hee Chung1.   

Abstract

Currently, the increasing numbers of vaccine administrations are associated with increased reports of adverse vaccine reactions. Whilst the general adverse reactions including allergic reactions caused by the vaccine itself or the vaccine components, are rare, they can in some circumstances be serious and even fatal. In accordance with many IgE-mediated reactions and immediate-type allergic reactions, the primary allergens are proteins. The proteins most often implicated in vaccine allergies are egg and gelatin, with perhaps rare reactions to yeast or latex. Numerous studies have demonstrated that the injectable influenza vaccine can be safely administered, although with appropriate precautions, to patients with severe egg allergy, as the current influenza vaccines contain small trace amounts of egg protein. If an allergy is suspected, an accurate examination followed by algorithms is vital for correct diagnosis, treatment and decision regarding re-vaccination in patients with immediate-type reactions to vaccines. Facilities and health care professionals should be available to treat immediate hypersensitivity reactions (anaphylaxis) in all settings where vaccines are administered.

Entities:  

Keywords:  Allergy; Anaphylaxis; Egg; Influenza; Vaccine

Year:  2013        PMID: 24427763      PMCID: PMC3890451          DOI: 10.7774/cevr.2014.3.1.50

Source DB:  PubMed          Journal:  Clin Exp Vaccine Res        ISSN: 2287-3651


  37 in total

1.  Raw egg allergy-a potential issue in vaccine allergy.

Authors:  J M Kelso
Journal:  J Allergy Clin Immunol       Date:  2000-11       Impact factor: 10.793

2.  Allergy to non-toxoid constituents of vaccines and implications for patch testing.

Authors:  N H Cox; C Moss; A Forsyth
Journal:  Contact Dermatitis       Date:  1988-03       Impact factor: 6.600

Review 3.  Vaccine hypersensitivity--update and overview.

Authors:  Philipp J Fritsche; Arthur Helbling; Barbara K Ballmer-Weber
Journal:  Swiss Med Wkly       Date:  2010-05-01       Impact factor: 2.193

4.  Hypersensitivity to tetanus toxoid.

Authors:  M A Facktor; R A Bernstein; P Fireman
Journal:  J Allergy Clin Immunol       Date:  1973-07       Impact factor: 10.793

5.  Anaphylaxis after hepatitis B vaccination.

Authors:  J T Lear; J S English
Journal:  Lancet       Date:  1995-05-13       Impact factor: 79.321

6.  Neomycin sensitivity and the MMR vaccine.

Authors:  R L Rietschel; R Bernier
Journal:  JAMA       Date:  1981-02-13       Impact factor: 56.272

7.  Bovine and porcine gelatin sensitivity in children sensitized to milk and meat.

Authors:  Jelena Bogdanovic; Neal A Halsey; Robert A Wood; Robert G Hamilton
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

8.  Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-07-09       Impact factor: 17.586

9.  Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy.

Authors:  Harumi Kuno-Sakai; Mikio Kimura
Journal:  Biologicals       Date:  2003-12       Impact factor: 1.856

10.  A case of anaphylactic shock attributed to latex allergy during gastric cancer surgery.

Authors:  Woohyung Lee; Jue Hee Lee; Do Joong Park; Hyung-Ho Kim
Journal:  J Korean Surg Soc       Date:  2011-11-25
View more
  27 in total

Review 1.  Vaccination policy in Korean armed forces: current status and future challenge.

Authors:  Jung Yeon Heo; Kang-Won Choe; Chang-Gyo Yoon; Hye Won Jeong; Woo Joo Kim; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

2.  First case of Stevens-Johnson syndrome after rabies vaccination.

Authors:  Li Ma; Xusheng Du; Yu Dong; Lirong Peng; Xiaonian Han; Jianhua Lyu; Hehe Bai
Journal:  Br J Clin Pharmacol       Date:  2018-02-09       Impact factor: 4.335

3.  Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.

Authors:  Yuleima Diaz; Morten L Govasli; Ephrem Debebe Zegeye; Halvor Sommerfelt; Hans Steinsland; Pål Puntervoll
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

4.  Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression.

Authors:  Nina Kim; Katie L Lannan; Thomas H Thatcher; Stephen J Pollock; Collynn F Woeller; Richard P Phipps
Journal:  J Immunol       Date:  2018-10-22       Impact factor: 5.422

5.  Analysis on the risks of severe adverse events in rabies post-exposure prophylaxis and appropriate decision-making procedure.

Authors:  Shichun Huang; Zhenggang Zhu; Li Cai; Zerong Zhu; Man Zhang; Quan Hu; Yuan Fang
Journal:  Hum Vaccin Immunother       Date:  2018-10-26       Impact factor: 3.452

6.  Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.

Authors:  Christophe Abi Zeid Daou; Mohammad A Natout; Nadine El Hadi
Journal:  J Med Virol       Date:  2021-06-06       Impact factor: 20.693

7.  Vaccination in children with allergy to non active vaccine components.

Authors:  Fabrizio Franceschini; Paolo Bottau; Silvia Caimmi; Giuseppe Crisafulli; Liotti Lucia; Diego Peroni; Francesca Saretta; Mario Vernich; Carlotta Povesi Dascola; Carlo Caffarelli
Journal:  Clin Transl Med       Date:  2015-02-14

8.  International Consensus (ICON): allergic reactions to vaccines.

Authors:  Stephen C Dreskin; Neal A Halsey; John M Kelso; Robert A Wood; Donna S Hummell; Kathryn M Edwards; Jean-Christoph Caubet; Renata J M Engler; Michael S Gold; Claude Ponvert; Pascal Demoly; Mario Sanchez-Borges; Antonella Muraro; James T Li; Menachem Rottem; Lanny J Rosenwasser
Journal:  World Allergy Organ J       Date:  2016-09-16       Impact factor: 4.084

9.  Cell culture-based production of defective interfering particles for influenza antiviral therapy.

Authors:  Milena A Wasik; Luca Eichwald; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

10.  Conserved and host-specific features of influenza virion architecture.

Authors:  Edward C Hutchinson; Philip D Charles; Svenja S Hester; Benjamin Thomas; David Trudgian; Mónica Martínez-Alonso; Ervin Fodor
Journal:  Nat Commun       Date:  2014-09-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.